Article
Clonal resistance analyses of HIV type-1 after failure of therapy with didanosine, lamivudine and tenofovir.
Antiviral therapy - 1 Jan 2010
Barnas Douglas, Koontz Dianna, Bazmi Holly, Bixby Christian, Jemsek Joseph, Mellors John W
Abstract excerpt
BACKGROUND: The rapid failure of initial therapy with combinations of nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs) that exclude zidovudine has not been fully explained by standard virus population analyses of HIV type-1 (HIV-1) drug resistance. We therefore investigated HIV-1 genotype and phenotype at the single genome level in samples from patients on a failing regimen of tenofovir (TNV),...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
